Hosted by Fortrea · 🇺🇸 US · EN · 10 episodes
Established thought leaders with verified media credentials.
Welcome to Hope in a Dose—the podcast where we explore the science, strategy, and stories behind the therapies redefining what’s possible.Designed for CGT innovators, this series helps you move smarter, faster, and with greater operational confidence.Across each episode, we unpack the real-world challenges sponsors face today: selecting truly CGT-capable sites, navigating early-phase risk, activating global trials in rare populations, and demonstrating meaningful clinical impact.Hosted by Lousie Kearney Head of Cell and Gene Therapy, Strategy and Delivery at Fortrea, a seasoned leader with decades of experience guiding emerging biotechs, Hope in a Dose equips CGT innovators, clinical sites, and Principal Investigators with practical tools to navigate the unique complexities of advanced therapy development.
Fortrea hosts Hope in a Dose: Cell & Gene Therapy, a health show with 10 episodes published.
In this episode, we talk through what sponsors really need to think about when navigating regulatory pathways for cell and gene therapies. We cover everything from early conversations with regulators and managing CMC ris
In this episode, Fortrea experts discuss how external control arms can enable efficient and ethical cell and gene therapy trials, particularly in rare diseases where traditional control arms are challenging. The conversa
In this episode we focus on one of the most dynamic regions in the CGT space: China. Why is this important? China has roughly become a major hub for cell and gene therapy research, driven by regulatory innovation, techno
In this episode we tackle one of the most critical aspects of these programs: long-term follow-up. Why is it so important? With CAR-T therapies, lentiviral vector-based treatments, and gene editing approaches requiring u
Expanding cell therapy beyond oncology opens new doors for patients—but it also introduces unique challenges in site identification and startup. From competing studies and resource limitations to regulatory nuances and c
Cell and gene therapy (CGT) trials are rewriting the rules of early-phase research. Unlike traditional first-in-human studies, these programs involve patients—not healthy volunteers—and often target rare or ultra-rare ge
In this episode of podcast series “Hope in a Dose” we discuss the essential elements for successful cell and gene therapy trials: understanding patient eligibility and journey, selecting the right sites, and acting with
In this episode we will discuss topics that are critical to the success of CGT programs: seamless collaboration between CDMOs and CROs. In cell and gene therapy, complexity isn't just in science, it's in the execution. A
Today we're diving into one of the most exciting frontiers in medicine: cell and gene therapy for pediatric diseases. Why is it so important? Part of the answer lies in the fact that cell and gene therapy offers somethin
Discover what sets cell and gene therapy (CGT) clinical trials apart. From “one-and-done” treatments to complex logistics and evolving regulations, our first episode of this podcast series explores the unique challenges
Detected from recent episode content. Sponsor presence is a real signal of listener purchasing power and show monetisation.
No public pitch examples yet for this show.
Generate your own personalised pitchBased on semantic analysis of episode topics and host coverage, this show is a strong guest fit for executives in:
Industry fit is computed by PitchCentric using vector embeddings of the show's episode catalog.
Shows with the most semantically similar episode content. Pitch one, pitch all; producers cluster.
Hope in a Dose: Cell & Gene Therapy has a verified contact on file. Create a free PitchCentric account to access it and generate a personalised pitch in seconds. Research at least 3 recent episodes first and lead with a specific angle that serves their health audience.
Hope in a Dose: Cell & Gene Therapy is hosted by Fortrea. The show is categorised under health (fitness) and has published 10 episodes.
Hope in a Dose: Cell & Gene Therapy has published 10 episodes.
Hope in a Dose: Cell & Gene Therapy regularly covers health, fitness, medicine. It sits in the health category, with a fitness focus.
Hope in a Dose: Cell & Gene Therapy is accessible for guests with genuine health expertise. A personalised, episode-aware pitch will still outperform a generic one every time.
Hope in a Dose: Cell & Gene Therapy hasn't explicitly signalled guest openness in recent episodes. That doesn't rule out pitching. your hook just needs to be especially compelling and relevant to their recent content.
Episodes of Hope in a Dose: Cell & Gene Therapy average 15 minutes. a focused format where a clear narrative arc and tight preparation matter most.
Our data rates Hope in a Dose: Cell & Gene Therapy's guest bar at 80/100 (Premium tier). Established thought leaders with verified media credentials. Sign in to PitchCentric to see how your own Pod Score compares against this show.
Methodology. Booking Probability™ blends Listen Score, 30-day Virality, open-to-guests detection, and Apple ratings. Data refreshed every 60 minutes. Listen Score and Booking Probability are calculated by PitchCentric. Last enriched 8 days ago.
